With the analysis among 280 patents, we discovered top 155 key players by total patent application. Regeneron Pharmaceuticals, Inc., Bristol Myers Squibb Co., Coöperatie AVEBE UA are dominant in this area. They take 8.93% of the total patent filing.
New York, United States
Patent: 9
New York, United States
Patent: 8
Groningen, Netherlands
Patent: 8
California, United States
Patent: 8
Michigan, United States
Patent: 6
California, United States
Patent: 4
Groningen, Netherlands
Patent: 4
With the analysis among 6 patents, we discovered top 3 start-ups by total patent application.
California, United States
Patent: 1
With the analysis among related 138 patents applied in the last 5 years. We discover 77 most active companies in this area. The fast-growing Regeneron Pharmaceuticals, Inc., Coöperatie AVEBE UA, Fuji Sekiyu KK take 16.67% of patent filing during this period.
New York, United States
Patent: 9
Groningen, Netherlands
Patent: 8
Groningen, Netherlands
Patent: 4
Bretagne, France
Patent: 3
undefined undefined
Patent: 3
Hyogo-ken, Japan
Patent: 2
Tianjin Shi, China
Patent: 2
With the analysis among related 138 patents in last 5 years, we discover 70 new entrants. Regeneron Pharmaceuticals, Inc., Coöperatie AVEBE UA, Fuji Sekiyu KK are the most active new entrants in this area.
New York, United States
Patent: 9
Groningen, Netherlands
Patent: 8
Groningen, Netherlands
Patent: 4
Bretagne, France
Patent: 3
undefined undefined
Patent: 3
Hyogo-ken, Japan
Patent: 2
Tianjin Shi, China
Patent: 2
With the analysis among 118 patents, we discovered top 45 universities and scientific research institutions by total patent application. University of Rennes, Montana State University, Jilin University are dominant in this area. They take 7.63% of the total patent filing.
Bretagne, France
Patent: 3
Montana, United States
Patent: 2
Jilin Sheng, China
Patent: 2
Aichi-ken, Japan
Patent: 2
Fukuoka-ken, Japan
Patent: 2
Guangdong Sheng, China
Patent: 2
Guangdong Sheng, China
Patent: 2
Tokyo Institute of Technology
Tianjin Shi, China
Patent: 2